How have HSCS shares performed in 2024?

Heart Test Laboratories' stock was trading at $17.10 at the beginning of 2024. Since then, HSCS stock has decreased by 62.1% and is now trading at $6.4879. View the best growth stocks for 2024 here .

When is Heart Test Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 16th 2024. View our HSCS earnings forecast .

How were Heart Test Laboratories' earnings last quarter?

Heart Test Laboratories, Inc. (NASDAQ:HSCS) announced its earnings results on Thursday, March, 14th. The company reported ($3.00) earnings per share (EPS) for the quarter. The firm had revenue of $0.02 million for the quarter.

When did Heart Test Laboratories' stock split?

Shares of Heart Test Laboratories reverse split on the morning of Friday, May 17th 2024. The 1-100 reverse split was announced on Friday, May 17th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

When did Heart Test Laboratories IPO?

Heart Test Laboratories (HSCS) raised $9 million in an IPO on Wednesday, June 15th 2022. The company issued 1,800,000 shares at $4.50-$5.50 per share. The Benchmark Company served as the underwriter for the IPO.

How do I buy shares of Heart Test Laboratories?

Shares of HSCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:HSCS

Heart Test Laboratories (HSCS) Stock Price, News & Analysis

→ What President Biden's new law means for investors (From Stansberry Research) (Ad)

Free HSCS Stock Alerts

$6.36

-0.61 (-8.75%)

(As of 12:53 PM ET)

Compare

Today's Range: $6.30
▼
$6.95
50-Day Range: $6.97
▼
$12.70
52-Week Range: $6.30
▼
$128.00

Volume: 101,133 shs
Average Volume: 34,983 shs
Market Capitalization: $4.20 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Ad InvestorPlace

Must-See: Elon’s New Invention is Absolutely Insane

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…

About Heart Test Laboratories Stock (NASDAQ:HSCS)

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

HSCS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HSCS Stock News Headlines

May 20 at 9:00 AM | globenewswire.com

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

May 19 at 3:21 AM | americanbankingnews.com

Heart Test Laboratories (NASDAQ:HSCS) Shares Gap Down to $11.31

May 17 at 12:15 PM | msn.com

Heart Test conducts 1-for-100 reverse stock split

April 30, 2024 | msn.com

Researchers develop genetic test for early detection of high cardiovascular risk

April 29, 2024 | abcnews.go.com

FDA brings lab tests under federal oversight in bid to improve accuracy and safety

April 24, 2024 | globenewswire.com

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

April 13, 2024 | msn.com

Roche Diagnostics India launches heart failure test for diabetics in India

April 4, 2024 | msn.com

Early coronary disease, impaired heart function found in asymptomatic people with HIV

April 4, 2024 | msn.com

The Importance of Regular Lipid Profile Testing For Cardiovascular Wellness

April 2, 2024 | globenewswire.com

HeartSciences to Present at the LD Micro Invitational XIV Conference

March 26, 2024 | globenewswire.com

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

March 15, 2024 | finanznachrichten.de

Heart Test Laboratories, Inc.: HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

March 14, 2024 | benzinga.com

Recap: Heart Test Laboratories Q3 Earnings

March 14, 2024 | finance.yahoo.com

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

March 14, 2024 | globenewswire.com

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

March 12, 2024 | morningstar.com

Heart Test Laboratories Inc

March 12, 2024 | finance.yahoo.com

HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

March 12, 2024 | globenewswire.com

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

March 6, 2024 | investorplace.com

Why Is Heart Test Laboratories (HSCS) Stock Down 21% Today?

March 6, 2024 | globenewswire.com

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

February 26, 2024 | globenewswire.com

HeartSciences Adds Key Advisor to its Scientific Advisory Board

February 24, 2024 | forbes.com

Best At-Home Blood Tests: A 2024 Guide

February 12, 2024 | finance.yahoo.com

HeartSciences Expands its Scientific Advisory Board

February 2, 2024 | msn.com

'Heart-on-a-chip' to test chemotherapies and other cancer drugs for heart toxicity

February 1, 2024 | msn.com

Promising heart drugs identified by cutting-edge combo of machine learning, human learning

See More Headlines

Company Calendar

Last Earnings: 3/14/2024
Today: 5/20/2024
Next Earnings (Estimated): 7/16/2024
Fiscal Year End: 4/30/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Current Symbol: NASDAQ:HSCS
CUSIP: N/A
CIK: 1468492
Web: heartsciences.com
Phone: 682-237-7781
Fax: N/A
Employees: 12
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($48.00)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-6,350,000.00
Net Margins: N/A
Pretax Margin: -33,636.84%
Return on Equity: -381.92%
Return on Assets: -134.17%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.09
Quick Ratio: 4.70

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.37 per share
Price / Book: 2.94

Miscellaneous

Outstanding Shares: 660,000
Free Float: 638,000
Market Cap: $4.60 million
Optionable: Not Optionable
Beta: 3.40

Key Executives

Mr. Andrew Simpson (Age 54)
CEO, President & Chairman of the Board of Directors
Comp: $264.14k
Ms. Danielle Watson (Age 41)
CFO & Treasurer
Comp: $188.75k
Mr. Mark T. Hilz (Age 65)
COO, Secretary & Director
Comp: $263.61k

Key Competitors

View All Competitors

HSCS Stock Analysis - Frequently Asked Questions

How have HSCS shares performed in 2024?: Heart Test Laboratories' stock was trading at $17.10 at the beginning of 2024. Since then, HSCS stock has decreased by 62.1% and is now trading at $6.4879.
View the best growth stocks for 2024 here.
When is Heart Test Laboratories' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 16th 2024.
View our HSCS earnings forecast.
How were Heart Test Laboratories' earnings last quarter?: Heart Test Laboratories, Inc. (NASDAQ:HSCS) announced its earnings results on Thursday, March, 14th. The company reported ($3.00) earnings per share (EPS) for the quarter. The firm had revenue of $0.02 million for the quarter.
When did Heart Test Laboratories' stock split?: Shares of Heart Test Laboratories reverse split on the morning of Friday, May 17th 2024. The 1-100 reverse split was announced on Friday, May 17th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

When did Heart Test Laboratories IPO?: Heart Test Laboratories (HSCS) raised $9 million in an IPO on Wednesday, June 15th 2022. The company issued 1,800,000 shares at $4.50-$5.50 per share. The Benchmark Company served as the underwriter for the IPO.
How do I buy shares of Heart Test Laboratories?: Shares of HSCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HSCS) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings